Nova Patents
IL233134D0

Pharmaceutical compositions comprising glitazones and nrf2 activators

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

46 members in 18 offices

This recordMember, by publication datePriority claim8 more offices are in the list below

Priority claims15

Priority claims
DocumentOfficeKindDate
11194292European Patent Office (EPO)A
12004652European Patent Office (EPO)A
201261663761United States of AmericaP
201213654632United States of AmericaA
2012074915European Patent Office (EPO)W
111942926–––
120046529–––
13654632–––
61663761–––
EP20110194292–––
EP20120004652–––
PCTEP2012074915–––
US201213654632–––
US201261663761P–––
WO2012EP74915–––

Members46

Family members, oldest first
DocumentOfficeKind
US2013158077A1United States of AmericaA1
CA2859635A1CanadaA1
WO2013092269A1World Intellectual Property Organization (WIPO)A1
US2013172391A1United States of AmericaA1
TW201334776ATaiwan Province of ChinaA
SG11201403241XASingaporeA
AU2012358420A1AustraliaA1
IL233134A0IsraelA0
IL233134D0This recordIsraelD0
MX2014007254AMexicoA
AR089301A1ArgentinaA1
CN103998035AChinaA
KR20140113689ARepublic of KoreaA
EP2793876A1European Patent Office (EPO)A1
CL2014001639A1ChileA1
EA201400729A1Eurasian Patent Organization (EAPO)A1
JP2015504871AJapanA
US2015133507A1United States of AmericaA1
HK1200711AHong Kong, ChinaA
HK1200711A1Hong Kong, ChinaA1
US9504679B2United States of AmericaB2
US2017065571A1United States of AmericaA1
JP6132850B2JapanB2
BR112014014809A2BrazilA2
BR112014014809A8BrazilA8
AU2012358420B2AustraliaB2
AU2012358420B9AustraliaB9
AU2017225019A1AustraliaA1
CN103998035BChinaB
AU2017225019B2AustraliaB2
AU2019204493A1AustraliaA1
US10426763B2United States of AmericaB2
US2019381023A1United States of AmericaA1
AU2019204493B2AustraliaB2
KR102188487B1Republic of KoreaB1
KR20200140384ARepublic of KoreaA
AU2021201390A1AustraliaA1
CA2859635CCanadaC
KR20220139414ARepublic of KoreaA
US11484530B2United States of AmericaB2
AU2021201390B2AustraliaB2
US2023190720A1United States of AmericaA1
EP2793876B1European Patent Office (EPO)B1
EP2793876C0European Patent Office (EPO)C0
ES2959111T3SpainT3
US12083107B2United States of AmericaB2